Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification

Background Malignant pleural mesothelioma (MPM) is a rare and aggressive neoplasia affecting the lung mesothelium. Immune checkpoint inhibitors (ICI) in MPM have not been extremely successful, likely due to poor identification of suitable candidate patients for the therapy. We aimed to identify cell...

Full description

Bibliographic Details
Main Authors: Victor Moreno, Ania Alay, David Cordero, Sara Hijazo-Pechero, Elisabet Aliagas, Adriana Lopez-Doriga, Raúl Marín, Ramón Palmero, Roger Llatjós, Ignacio Escobar, Ricard Ramos, Susana Padrones, Xavier Solé
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/2/e001601.full